Molina Healthcare, Inc. (NYSE:MOH) Shares Sold by Scion Asset Management LLC

Scion Asset Management LLC lessened its stake in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 16.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 25,000 shares of the company's stock after selling 5,000 shares during the quarter. Molina Healthcare comprises about 9.4% of Scion Asset Management LLC's investment portfolio, making the stock its 5th largest holding. Scion Asset Management LLC's holdings in Molina Healthcare were worth $7,276,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in MOH. Tributary Capital Management LLC increased its stake in shares of Molina Healthcare by 76.1% in the 4th quarter. Tributary Capital Management LLC now owns 4,190 shares of the company's stock valued at $1,219,000 after acquiring an additional 1,811 shares during the last quarter. Smartleaf Asset Management LLC grew its holdings in Molina Healthcare by 123.9% during the fourth quarter. Smartleaf Asset Management LLC now owns 347 shares of the company's stock valued at $100,000 after purchasing an additional 192 shares during the period. SYM FINANCIAL Corp bought a new stake in Molina Healthcare in the fourth quarter valued at approximately $249,000. Summit Trail Advisors LLC acquired a new stake in Molina Healthcare in the fourth quarter worth $452,000. Finally, Entropy Technologies LP boosted its position in shares of Molina Healthcare by 58.1% during the fourth quarter. Entropy Technologies LP now owns 4,594 shares of the company's stock worth $1,337,000 after purchasing an additional 1,688 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company's stock.

Analyst Ratings Changes

MOH has been the subject of a number of recent analyst reports. Wells Fargo & Company upgraded shares of Molina Healthcare from an "equal weight" rating to an "overweight" rating and upped their price objective for the company from $295.00 to $372.00 in a research report on Wednesday, March 5th. Robert W. Baird restated a "neutral" rating and issued a $375.00 price target (up from $331.00) on shares of Molina Healthcare in a report on Tuesday, April 15th. Guggenheim initiated coverage on Molina Healthcare in a report on Wednesday, April 9th. They set a "neutral" rating on the stock. Barclays increased their target price on Molina Healthcare from $339.00 to $362.00 and gave the stock an "equal weight" rating in a research note on Friday, April 25th. Finally, Stephens reaffirmed an "equal weight" rating and issued a $345.00 price target on shares of Molina Healthcare in a research note on Thursday, February 6th. Nine analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $365.38.

Insider Activity

In related news, Director Richard M. Schapiro sold 669 shares of the business's stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total transaction of $214,414.50. Following the transaction, the director now directly owns 11,244 shares in the company, valued at approximately $3,603,702. The trade was a 5.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the completion of the sale, the chief executive officer now owns 257,715 shares of the company's stock, valued at approximately $82,484,262.90. This represents a 25.35% decrease in their position. The disclosure for this sale can be found here. Insiders sold 89,169 shares of company stock worth $28,520,995 in the last quarter. Corporate insiders own 1.10% of the company's stock.

Molina Healthcare Trading Up 3.5%

NYSE:MOH opened at $325.02 on Friday. The company has a market cap of $17.62 billion, a P/E ratio of 15.91, a price-to-earnings-growth ratio of 1.06 and a beta of 0.63. Molina Healthcare, Inc. has a twelve month low of $262.32 and a twelve month high of $365.23. The business has a 50 day moving average price of $324.07 and a two-hundred day moving average price of $308.43. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, topping the consensus estimate of $5.96 by $0.12. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The business had revenue of $11.15 billion during the quarter, compared to analysts' expectations of $10.86 billion. During the same quarter in the prior year, the company posted $5.73 earnings per share. The firm's revenue was up 12.2% on a year-over-year basis. As a group, analysts expect that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc. (NYSE:MOH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.